GBECAM
@GBECAMConnect
Followers
91
Following
23
Media
38
Statuses
62
Research, education, and support to improve breast cancer care in Brazil.
Salvador, Brasil
Joined November 2024
TODAY: Save the Date: GBECAM Connection – May 6, 2025! 🌍 An exclusive session in English, with simultaneous translation (EN–PT) to make it accessible for all! 📅 Date: Tuesday, May 6, 2025 🕖 Time: 🇧🇷 7:00–8:30 PM (BRT) 🇮🇹 Milan: 11:00 PM (UTC+2) 🇺🇸 Boston: 6:00 PM (UTC-4) 📍
0
0
1
New Brazilian real-world data from GBECAM members: only 58.7% of women with nonmetastatic ER+ breast cancer adhered to adjuvant endocrine therapy. Better QoL linked to better adherence. Urgent need for survivorship support. 🔗 Full text available https://t.co/sJ8mRFHx95
ascopubs.org
PURPOSEAdjuvant endocrine therapy (ET) improves the prognosis of patients with nonmetastatic estrogen receptor–positive (ER+) breast carcinoma; however, adherence is crucial to ensure its efficacy....
1
2
4
Convite para o Tumor Board do GBECAM Temos o prazer de convidá-los para o Tumor Board do GBECAM, um evento dedicado à discussão multidisciplinar de casos em oncologia mamária. Esta iniciativa visa promover a colaboração entre especialistas para otimizar a tomada de decisões e
0
2
2
Amazing talk by @drsarahsam at @GBECAMConnect Conference last week! Thank you so much for such great discussions and insights for future plans. We'll be waiting for you in Recife next time around! 😎🏝️
A few highlights from my ADC resistance talk at @LACOG_group @GBECAMConnect 1) T-DXd works after T-DM1, diff payload, stronger ADC 2) 2nd TOP1 ADC performs inferiorly 3) Muts in TROP2 and TOP1--> resistance 4) ⬇️target occurs post T-DXd 5) New ADCs with diverse payloads needed
0
3
8
GBECAM - Maryam Lustberg on optimizing post-cancer life management @GBECAMConnect @maryam_lustberg @YaleCancer
https://t.co/zSmNGQgHgW
#OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #PostCancerLifeManagement #TNBC
oncodaily.com
Maryam Lustberg on optimizing post-cancer life management - GBECAM / cancer, GBECAM, Juliana Beal, Maria Cristina Figueroa, Maryam Lustberg, OncoDaily,
0
1
14
Honored to participate in the 2025 LACOG-GBECAM Brazilian Breast Cancer Conference - Leandro Jonata Carvalho (@LeandroJonatad1) @LACOG_group @GBECAMConnect
https://t.co/Kr2pNi7KbQ
#OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc
oncodaily.com
Leandro Jonata Carvalho: Honored to participate in the 2025 LACOG-GBECAM Brazilian Breast Cancer Conference / 2025 LACOG-GBECAM Brazilian Breast Cancer
0
2
17
A few highlights from my ADC resistance talk at @LACOG_group @GBECAMConnect 1) T-DXd works after T-DM1, diff payload, stronger ADC 2) 2nd TOP1 ADC performs inferiorly 3) Muts in TROP2 and TOP1--> resistance 4) ⬇️target occurs post T-DXd 5) New ADCs with diverse payloads needed
0
22
61
Starting day 2 with a key topic! Case-based discussion on metastatic ER+/HER2- breast cancer! @LACOG_group
@crisonco @maryam_lustberg @itsnot_pink Mayana Lopes, José Bines, Cristiano Pádua.
0
1
6
Hot Topics in Young Patients, Fertility, and Disparities in Breast Cancer: What We Learned in 2024 A powerful session with key takeaways we should keep top of mind every day. 🧠🎗️🩺 @maryam_lustberg @LeandroJonatad1 @PedroExman @LauraTestaMD @DraSSanches JesséLopes
0
3
7
🎉 Congratulations, @renata_bonadio ! Winner of the 2025 GBECAM Research Support Fund (FIP) project! We’re so proud of this amazing achievement! 🙌🔬✨
0
0
1
Best of SABCS 2024 – Advanced Breast Cancer 🧬 Featuring an amazing panel: @DGagliato , Carlos dos Anjos, Aline Gonçalves, Andrea Shimada, Otto Metzker & Gisah Guilgen! 💬✨ #BreastCancer #SABCS2024 #Oncology
0
0
2
Maryam Lustberg @maryam_lustberg Chief of Breast Oncology and Director of the Breast Center at Yale Cancer Center in New Haven Connecticut) sharing insights on Optimizing Post-Cancer Life Management: challenges & strategies in the journey of patients with triple-negative breast
1
1
6
The largest Brazilian conference in breast cancer started today - @GBECAMConnect . @itsnot_pink is giving us a lecture that comes with the most important lesson: nothing happens in oncology without the patient! They are why we do what we do 🤍
1
7
22
Abertura oficial da Conferência Brasileira de Câncer de Mama LACOG-GBECAM 2025 @LACOG_group @LucianaLandeiro @GustavoWerutsky
0
1
3
🔗 Acesso pelo link https://t.co/WZw9cbX59N
us02web.zoom.us
Zoom is the leader in modern enterprise cloud communications.
0
0
0
‼️HOJE, NÃO PERCA‼️ Junte-se a nós no Tumor Board em Câncer de Mama no GBECAM. @GBECAMConnect Data: 19/02/2025 (Quarta-feira) Horário: 19:00 - 20:30 Coordenadores: 🔹Dra. Solange Sanches: Oncologista (SP) @DraSSanches 🔹Dr. Cristiano Resende: Oncologista (DF) @crisonco
1
1
2
2025 is anticipated to be the year with the highest number of phase 3 ADC trials read outs in breast oncology, with impact for all breast cancer subtypes. Here’s 8 ADC breast cancer trials expected to reshape practice in 2025:
6
88
249
Nos dias 28 e 29 de março de 2025, São Paulo será palco da Conferência Brasileira de Câncer de Mama LACOG - GBECAM 2025 (@LACOG_group @GBECAMConnect ). Garanta sua participação gratuita realizando a inscrição no site oficial: https://t.co/DYgQdcZ8Ox.
0
1
1
